SciELO - Scientific Electronic Library Online

 
vol.58 número5Política de actuación de la biopsia transrectal prostática, en mayores de 50 años, en función del valor del PSA, elaborado mediante un árbol de decisión matemáticoCerebelo y tracto urinario inferior índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Archivos Españoles de Urología (Ed. impresa)

versión impresa ISSN 0004-0614

Resumen

ARES VALDES, Yolanda  y  FRAGAS VALDES, Ramiro. Incidental renal cell carcinoma. Arch. Esp. Urol. [online]. 2005, vol.58, n.5, pp.417-420. ISSN 0004-0614.

OBJECTIVES: To report the incidence and management of incidental renal cell carcinoma (RCC). METHODS: We performed a retrospective longitudinal and panel study for our case series between January 1990 and December 2003. Thirty cases of RCC were analyzed, 6 of which were incidental. RESULTS: 4 patients were males (66.6%) and 2 females (33.3%); age ranged between 28 and 72 years. Reason for consultation was related with gastrointestinal symptoms. Ultrasound and CT scan are the most useful studies. Clinical stage was 4 T1(66.6%), 2 T2 (33.3%). 4 radical nephrectomies and 2 conservative surgeries (partial nephrectomy and tumorectomy) were performed. A dose of 3 million units of alpha 2b recombinant interferon (IFN alpha 2b r) was given Intramuscularly two times a week over 6 months. Follow-up ranged between 120 and 60 months and none of the patients had evidence of tumor activity. CONCLUSIONS: The incidence of incidental RCC in our hospital is 20%. Clinical stage was always low and survival is directly related to stage. Conservative surgery showed similar survival than radical surgery.

Palabras clave : Renal cell carcinoma; Incidental; Survival; Stage; Interferon.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons